Our Today is Your Tomorrow.

At Troy we continue to be at the forefront of the latest research and development in animal health. We strive to exceed the expectations of industry and animal owners alike.

The future of our business is to continue the high levels of engagement we have across all of our industry partners. Today, as it has been the for the past 50 years we are unwavering in our focus on the health and well being of companion and production animals.

As a family owned company we embrace the same philosophy with our internal Staff as we do our commitment to our customers and the future of their animals

About Troy Labs

Our History

Troy Laboratories was established by Veterinarians whose common goal of Innovation, Quality and Affordability; is still at the forefront of our business today.

Since 1959 we have been proud to provide the Australian community with Australian manufactured products that ensure optimal welfare for pets and production animals. We were proud to open our new, purpose built state-of-the-art facilities in Glendenning in 2010. With your valued and continued support, we are planning many more years of service, dedication and innovation.

We currently have over 140 products registered (Troy and Ilium) in Australia and global markets. We continue to provide our customers and animals alike with significant investments in Research & Development projects and new product registrations for their future health and wellbeing.

You can be assured that our products are 100% Australian owned and made. At Troy Laboratories we are driven by upholding our valued partnerships with veterinarians, professional bodies and pet owners through our continued support of animal health industries and associations.


The future of Troy Laboratories is being led by a team that has over 130 years’ combined experience in veterinary science, human pharmaceuticals, GMP/ISO manufacturing and global financial management. This is the team I trust to bring you the highest quality veterinary pharmaceuticals in the business. – Ian Saunders, CEO